Menu

GM Study Declared Unsound

A controversial study that suggested genetically modified (GM) maize causes cancer in rats is dismissed by the European Food Safety Authority.

Nov 29, 2012
Jef Akst

Wikimedia, Sreejith KA task force set up by the European Food Safety Authority (EFSA) yesterday (November 28) has confirmed suspicions that a September study claiming to have identified serious health consequences of genetically modified (GM) maize “does not meet acceptable scientific standards.”

The 2-year-long study examined rats fed a Europe- and United States-approved GM corn, called NK603, and claimed they developed massive mammary tumors and died earlier than rats fed conventional corn. The results, which were published in September in Food and Chemical Toxicology, were met with immediate skepticism, leading to an independent evaluation by two French regulatory agencies and the EFSA. Last month (October 4), the EFSA announced its preliminary conclusion that “the design, reporting and analysis of the study, as outlined in the paper, are inadequate.” Now, the agency has declared with more certainty that the study “does not meet acceptable scientific standards, and there is no need to re-examine previous safety evaluations of genetically modified maize NK603.”

The European Union uses millions of tons of GM crops, including NK603 corn, as livestock feed.

(Hat tip to ScienceInsider)

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.